Tiziana Life Sciences PLC logo
Tiziana Life Sciences PLC TLSA
$ 0.99 6.51%

Annual report 2023
added 12-07-2024

report update icon

Tiziana Life Sciences PLC Balance Sheet 2011-2024 | TLSA

Annual Balance Sheet Tiziana Life Sciences PLC

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - -3.94 M 186 K -4.48 M -8.69 M -2.06 M 169 K -4 K -33 K

Long Term Debt

- - - - - - - - - - - - -

Long Term Debt Current

138 K 122 K - 265 K 279 K - - - - - - - -

Total Non Current Liabilities

- - - 290 K 411 K - - - - - - - -

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

6.65 M 6.91 M 7.55 M 8.27 M 7.89 M 6.4 M 3.51 M 1.74 M 746 K 683 K 272 K 136 K 100 K

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

- - - -84.6 M -43.1 M -39.9 M -29.8 M 11 M -12.2 M -3.59 M -21.4 M -21.1 M -20.5 M

Total Assets

12.2 M 26.5 M 48.8 M 70.7 M 2.38 M 6.92 M 1.83 M 5.05 M 9.25 M 2.46 M 126 K 96 K 625 K

Cash and Cash Equivalents

1.18 M 18.1 M 42.2 M 65.8 M 200 K 5.3 M 64 K 5.8 M - - - - -

Book Value

5.54 M 19.6 M 41.3 M 62.4 M -5.51 M 519 K -1.68 M 3.31 M 8.5 M 1.78 M -146 K -40 K 525 K

Total Shareholders Equity

- - - 62.4 M -5.51 M 519 K -2.28 M 4.09 M - - - - -

All numbers in USD currency

Quarterly Balance Sheet Tiziana Life Sciences PLC

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - 290 K - - - 541 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 7.55 M - - - 8.27 M - - - 7.89 M - - - 6.4 M - - - 4.75 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -108 M - - - -84.6 M - - - -60 M - - - -50.7 M - - - -42.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 48.8 M - - - 70.7 M - - - 2.38 M - - - 6.92 M - - - 2.47 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 42.2 M - - - 65.8 M - - - 200 K - - - 5.3 M - - - 64 K - - - 5.8 M - - - 13.1 M - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 41.3 M - - - 62.4 M - - - -5.51 M - - - 519 K - - - -2.28 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 41.3 M - - - 62.4 M - - - 69.6 M - - - 75.8 M - - - -2.28 M - - - 4.09 M - - - 12.5 M - - - - - - - - - - - - - - - - - - -

All numbers in USD currency